Page last updated: 2024-08-24

ibandronic acid and Embolism, Pulmonary

ibandronic acid has been researched along with Embolism, Pulmonary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bergström, B; Body, JJ; Diel, I; Pecherstorfer, M; Rivkin, S	1

Trials

1 trial(s) available for ibandronic acid and Embolism, Pulmonary

Article	Year
Long-term safety of intravenous ibandronic acid for up to 4 years in metastatic breast cancer: an open-label trial. Clinical drug investigation, 2006, Volume: 26, Issue:6 Topics: Adult; Aged; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Creatinine; Diphosphonates; Disease Progression; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Ibandronic Acid; Infusions, Intravenous; Injections, Intravenous; Leg; Middle Aged; Neoplasm Metastasis; Pulmonary Embolism; Survival Rate; Thrombosis; Time Factors; Treatment Outcome	2006

Article

Year

Long-term safety of intravenous ibandronic acid for up to 4 years in metastatic breast cancer: an open-label trial.

Clinical drug investigation, 2006, Volume: 26, Issue:6

Topics: Adult; Aged; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Creatinine; Diphosphonates; Disease Progression; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Ibandronic Acid; Infusions, Intravenous; Injections, Intravenous; Leg; Middle Aged; Neoplasm Metastasis; Pulmonary Embolism; Survival Rate; Thrombosis; Time Factors; Treatment Outcome

2006